Informal consultation on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis - 1 May 2020
1 May 2020
     | Publication
  
     Overview
Agenda items
- Meeting agenda and Goal (Chair)
 - Proposed way forward for generating evidence and scope of the core Data Monitoring committee (WHO, Tom Fleming)
 - MRI data and statistical platform (BMGF)
 - Current landscape and progress update for PrEP studies (BMGF, Principal Investigators)
 - Current landscape and progress update for PEP studies (BMGF, Principal Investigators)
 - Progress update for Core PrEP and PEP protocols (WHO, Ira Longini)
 - AOB and action points
 
All consultations on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis
WHO Team
         
                 
R&D Blue Print (RDB)                 
         
        Number of pages
         9